Doctors for the first time can determine which medication is more likely to help a patient overcome depression, according to research that pushes the medical field beyond what has essentially been a guessing game of prescribing antidepressants.
A blood test that measures a certain type of protein level provides an immediate tool for physicians who until now have relied heavily on patient questionnaires to choose a treatment, said Dr. Madhukar Trivedi, who led the research at UT Southwestern Medical Center’s Center for Depression Research and Clinical Care.
“Currently, our selection of depression medications is not any more superior than flipping a coin, and yet that is what we do. Now we have a biological explanation to guide treatment of depression,” said Dr. Trivedi, Director of the depression center, a cornerstone of UT Southwestern’s Peter O’Donnell Jr. Brain Institute.
The study demonstrated that measuring a patient’s C-reactive protein (CRP) levels through a simple finger-prick blood test can help doctors prescribe a medication that is more likely to work. Utilizing this test in clinical visits could lead to a significant boost in the success rate of depressed patients who commonly struggle to find effective treatments.
A major national study Dr. Trivedi led more than a decade ago (STAR*D) gives insight into the prevalence of the problem: Up to a third of depressed patients don’t improve during their first medication, and about 40 percent of people who start taking antidepressants stop taking them within three months.
“This outcome happens because they give up,” said Dr. Trivedi, whose previous national study established widely accepted treatment guidelines for depressed patients. “Giving up hope is really a central symptom of the disease. However, if treatment selection is tied to a blood test and improves outcomes, patients are more likely to continue the treatment and achieve the benefit.”
The new research published in Psychoneuroendocrinology measured remission rates of more than 100 depressed patients prescribed either escitalopram alone or escitalopram plus bupropion. Researchers found a strong correlation between CRP levels and which drug regimen improved their symptoms:
- For patients whose CRP levels were less than 1 milligram per liter, escitalopram alone was more effective: 57 percent remission rate compared to less than 30 percent on the other drug.
- For patients with higher CRP levels, escitalopram plus bupropion was more likely to work: 51 percent remission rate compared to 33 percent on escitalopram alone.
Dr. Trivedi noted that these results could readily apply to other commonly used antidepressants.
“These findings provide evidence that a biological test can immediately be used in clinical practice,” he said.
Dr. Trivedi identified CRP as a potential marker for depression treatments because it has been an effective measure of inflammation for other disorders such as cardiovascular disease and diabetes.
While previous research to establish CRP as an antidepressant marker used levels three to five times higher than the latest study, “my theory was that you don’t need that high of an inflammation to experience the sickness of depression,” Dr. Trivedi said. “Even a little inflammation may be sufficient for the patients to experience some of these symptoms of depression.”
The next step is to conduct larger studies to verify CRP’s role with other antidepressants and find alternative markers where CRP does not prove effective. Dr. Trivedi said these studies could lead to additional useful biological tests that can be used in practice.
“Both patients and primary-care providers are very desperately looking for markers that would indicate there is some biology involved in this disease. Otherwise, we are talking about deciding treatments from question-and-answer from the patients, and that is not sufficient,” said Dr. Trivedi, a Professor of Psychiatry who holds the Betty Jo Hay Distinguished Chair in Mental Health and is the inaugural holder of the Julie K. Hersh Chair for Depression Research and Clinical Care.
The data reviewed for the study came from the CO-MED trial, which was funded by the National Institute of Mental Health. The work was also supported through UT Southwestern’s Center for Depression Research and Clinical Care and The Hersh Foundation.
Other UT Southwestern researchers include Dr. Manish Jha, Dr. Abu Taher Minhajuddin, Dr. Bharathi Gadad, Dr. Tracy Greer, Bruce Grannemann, Dr. Abigail Soyombo and Taryn Mayes. Dr. A. John Rush, Professor Emeritus, Duke-National University of Singapore also collaborated on the publication.
“With advances in technology and our understanding of the biology of depression, our ongoing work with additional biomarkers is likely to yield tests for other subtypes of depression,” said Dr. Jha, Assistant Professor of Psychiatry.
The Latest on: Depression
via Google News
The Latest on: Depression
Cyclone Vayu Weakens, To Cross Gujarat Coast As "Depression"
on June 17, 2019 at 2:07 am
Cyclone Vayu has weakened and is likely to cross the Gujarat coast by Monday midnight as a "depression", the weatherman said. However, the Kutch district administration is on alert as the cyclone can ... […]
Myth or Fact: Obesity, diabetes, high blood pressure and depression are related to sleep?
on June 17, 2019 at 1:02 am
When it comes to your health, trying to make the best decisions can be confusing with all the articles and new studies being released daily. That is why FOX 8 has teamed up with Dr. Marc with the ... […]
Why Zendaya's 'Euphoria' Character's Addiction & Depression Speaks Directly To Gen Z
on June 16, 2019 at 8:02 pm
Content warning: This post contains discussion of substance abuse that some may find triggering. Spoilers ahead for Euphoria's premiere episode. HBO's Euphoria is an unflinching look at a group of ... […]
‘90 Day Fiancé’ Cast Update: Ashley Claims Jay Caused Depression Before Rehab
on June 16, 2019 at 12:43 pm
“90 Day Fiancé: Happily Ever After?” Season 4 couple Ashley Martson and Jay Smith’s marriage may be over, but it doesn’t mean they have forgotten about the relationship they once shared. Although the ... […]
When Depression Turns Sleep Into a Dangerous Neighborhood
on June 16, 2019 at 12:39 pm
“They should give you a day off work after a bad dream,” I say, knowing it will make my colleagues laugh. “Seriously, I need a week to recover after some of the stuff I have to deal with when I’m ... […]
Brandi Glanville got depression from 'mold'
on June 16, 2019 at 1:00 am
Brandi Glanville has been suffering a "weird depression" caused by "mold poisoning". The 46-year-old reality star recently had to leave her Los Angeles home after discovering an infestation of black ... […]
Guys Are Sharing How They've Helped Friends Deal With Depression
on June 15, 2019 at 9:27 am
Mental health remains a subject surrounded by stigma, which is slowly being broken down through open and honest conversations. Communication on this topic is especially crucial for men, who often ... […]
Father Shares His Battle with Postpartum Depression After Birth of First Son
on June 14, 2019 at 4:33 pm
A Kansas City father is speaking out about his battle with postpartum depression following the birth of his first son. ... […]
Depression Called a 'Core Symptom' of MS
on June 14, 2019 at 1:35 pm
SEATTLE — Because brain imaging studies increasingly show that depression experienced by patients with multiple sclerosis (MS) may be linked as much to brain changes caused by the disease itself as to ... […]
via Bing News